Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.42 USD
+0.02 (4.95%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $0.43 +0.01 (2.38%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Bionano Genomics, Inc. [BNGO]
Reports for Purchase
Showing records 21 - 37 ( 37 total )
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
4Q18 Recap - Strong Quarter and Runway Extended
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Model Update - Still Confident, but More Conservative
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We are transferring lead coverage to Scott Henry due to the departure of the previous lead-covering analyst
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Productive ASHG 2018, Several Posters on Saphyr and Two Announcements
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: Bionano Genomics, Inc.
Industry: Unclassified
MORNING - MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We initiate coverage with a Buy rating and a $12.00/ share price target.
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D